Literature DB >> 21854498

Peripheral nerve field stimulation in the treatment of postlaminectomy syndrome after multilevel spinal surgeries.

Alexander E Yakovlev1, Beth E Resch, Victoria E Yakovleva.   

Abstract

INTRODUCTION: Chronic low back pain in patients with postlaminectomy syndrome (PLS) is challenging to treat, especially for patients who have undergone multilevel surgical procedures. Despite conservative therapy and available interventional pain procedures including spinal cord stimulation (SCS) and intrathecal therapies, patients may continue with intractable low back pain. Peripheral nerve field stimulation (PNFS) may represent an effective alternative treatment option for these patients when conventional treatments do not provide adequate relief of intractable low back pain.
METHODS: Eighteen patients underwent an uneventful PNFS trial with percutaneous placement of four temporary quadripolar leads (Medtronic, Inc., Minneapolis, MN, USA) placed subcutaneously over the lumbar or thoraco-lumbar area.
RESULTS: After experiencing excellent pain relief over the next two days, temporary leads were removed. The patients were implanted with permanent leads and rechargeable or non-rechargeable generator two to four weeks after temporary lead removal. All patients reported sustained pain relief 12 months after implantation. DISCUSSION: PNFS with use of four vertically orientated leads provides an effective treatment option for patients with PLS after multilevel surgical procedures with intractable low back pain who have failed conservative treatment. PNFS may provide pain relief with advantages over conservative treatments and interventional treatments including SCS and intrathecal therapy.
CONCLUSION: PNFS may be more effective in treating intractable low back pain than SCS in patients with PLS after multilevel spinal surgeries.
© 2011 International Neuromodulation Society.

Entities:  

Mesh:

Year:  2011        PMID: 21854498     DOI: 10.1111/j.1525-1403.2011.00387.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  7 in total

1.  Ethical challenges and interventional pain medicine.

Authors:  Gary J Brenner; Karsten Kueppenbender; Jianren Mao; Jeffrey Spike
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Infection Rates of Electrical Leads Used for Percutaneous Neurostimulation of the Peripheral Nervous System.

Authors:  Brian M Ilfeld; Rodney A Gabriel; Michael F Saulino; John Chae; P Hunter Peckham; Stuart A Grant; Christopher A Gilmore; Michael C Donohue; Matthew G deBock; Amorn Wongsarnpigoon; Joseph W Boggs
Journal:  Pain Pract       Date:  2016-11-11       Impact factor: 3.183

3.  Bilateral Peripheral Nerve Field Stimulation for Intractable Coccygeal Pain: A Case Study Using Dual Lead Intercommunication.

Authors:  Michelle Granville; Patrick T Brennan; Robert E Jacobson
Journal:  Cureus       Date:  2017-11-09

4.  Assessing the effectiveness and cost effectiveness of subcutaneous nerve stimulation in patients with predominant back pain due to failed back surgery syndrome (SubQStim study): study protocol for a multicenter randomized controlled trial.

Authors:  Sam Eldabe; Michael Kern; Wilco Peul; Colin Green; Kristi Winterfeldt; Rod S Taylor
Journal:  Trials       Date:  2013-06-25       Impact factor: 2.279

Review 5.  Spinal cord stimulation for neuropathic pain: current perspectives.

Authors:  Tilman Wolter
Journal:  J Pain Res       Date:  2014-11-18       Impact factor: 3.133

Review 6.  Interventional Therapies for Chronic Low Back Pain: A Focused Review (Efficacy and Outcomes).

Authors:  Vikram B Patel; Ronald Wasserman; Farnad Imani
Journal:  Anesth Pain Med       Date:  2015-08-22

7.  A Randomized Controlled Trial of Subcutaneous Nerve Stimulation for Back Pain Due to Failed Back Surgery Syndrome: The SubQStim Study.

Authors:  Sam S Eldabe; Rod S Taylor; Stefaan Goossens; Benedicte Bouche; Ismail Gültuna; Colin Green; Jennifer Tinsley; Pierre-Philippe Luyet; Eric Buchser
Journal:  Neuromodulation       Date:  2018-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.